NEW YORK (GenomeWeb) – Olink AB announced today that it has completed a reorganization and has split into two separate companies — Olink Proteomics and Olink Bioscience.

Olink Proteomics will continue to expand and develop the Proseek Multiplex human protein biomarker discovery product portfolio and is aiming to create a variety of high-quality multiplex immunoassays for biomarker discovery as well as diagnostic tools based on clinically relevant protein signatures.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.